Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Apr 15, 2025 (1 years ago)

Rapidol Arnica Tablets

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

cGMP deviations

Cause type: cGMP deviation

Departures from current Good Manufacturing Practice found in production or during FDA inspection. A broad quality-system cause: the batch was made under conditions that fall short of FDA manufacturing standards. All cgmp deviation recalls.

What was recalled

Rapidol Arnica Tablets, Homeopathic Medicine, 100-count bottle, Distributed by: Pharmadel, New Castle, DE 19720, NDC 55758-405-99

Affected NDC 55758-0405-99

Compare with the code on your package — it is the most precise check available.

Drug: Arnica

Recalling firm
Pharmadel, LLC
NDC code
55758-405-99
Origin
DE, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0383-2025 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Arnica recalls

See all
Class II · Moderate risk

ZTE-1035 Formula

Out-of-specification test results obtained for identification testing based on HPTLC analysis.

Terminated Failed specification Washington Homeopathic Products, Inc. D-0886-2021

Other recalls by Pharmadel, LLC

All 2025 recalls
Class II · Moderate risk

Urodel

cGMP deviations

Terminated cGMP deviation Pharmadel, LLC NDC 55758-406-30 D-0384-2025
Class II · Moderate risk

Kingskin

cGMP deviations

Terminated cGMP deviation Pharmadel, LLC NDC 55758-409-15 D-0381-2025